Y Terashima Selected Research

propagermanium (Ge 132)

6/2001

An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y Terashima Research Topics

Disease

4	Neoplasms (Cancer) 09/2013 - 01/2000
3	Inflammation (Inflammations) 02/2022 - 06/2001
3	Pain (Aches) 05/2016 - 09/2000
3	Body Weight (Weight, Body) 04/2006 - 05/2002
2	Radiculopathy (Radiculopathy, Cervical) 05/2016 - 09/2012
2	Neoplasm Metastasis (Metastasis) 09/2013 - 09/2000
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2001 - 01/2000
1	Rheumatoid Arthritis 09/2019
1	Necrosis 09/2019
1	Neuralgia (Stump Neuralgia) 05/2016
1	Type 2 Diabetes Mellitus (MODY) 06/2014
1	Adenocarcinoma of Lung 09/2013
1	Carcinogenesis 09/2013
1	Hyperalgesia 09/2012
1	Diabetes Mellitus 05/2009
1	Arteriosclerosis 05/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2007
1	Insulin Resistance 04/2006
1	Weight Gain 07/2004
1	Chronic Hepatitis B 06/2001
1	Adenocarcinoma 01/2001
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2001
1	Breast Neoplasms (Breast Cancer) 01/2001
1	Ovarian Neoplasms (Ovarian Cancer) 12/2000
1	Ovarian Epithelial Carcinoma 12/2000
1	Hypersensitivity (Allergy) 12/2000
1	Edema (Dropsy) 12/2000
1	Hypercalcemia (Milk Alkali Syndrome) 09/2000
1	Hepatocellular Carcinoma (Hepatoma) 09/2000
1	Bone Resorption 09/2000
1	Liver Neoplasms (Liver Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

3	GhrelinIBA 04/2006 - 07/2004
2	ChemokinesIBA 09/2013 - 02/2007
1	CytokinesIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2016
1	Yohimbine (Yocon)IBA 05/2016
1	Prazosin (Minipress)FDA LinkGeneric 05/2016
1	Phentolamine (Z-Max)FDA LinkGeneric 05/2016
1	Liraglutide FDA Link 06/2014
1	ErbB Receptors (EGF Receptor)IBA 09/2013
1	LigandsIBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	Messenger RNA (mRNA)IBA 09/2013
1	Chemokine ReceptorsIBA 09/2013
1	CCR7 ReceptorsIBA 09/2013
1	oxidized low density lipoproteinIBA 05/2009
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2009
1	HDL CholesterolIBA 05/2009
1	Interleukin-8 (Interleukin 8)IBA 02/2007
1	Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 04/2006
1	Growth Hormone (Somatotropin)IBA 07/2004
1	ChitosanIBA 05/2002
1	propagermanium (Ge 132)IBA 06/2001
1	PolymersIBA 06/2001
1	AcidsIBA 06/2001
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2001
1	doxifluridineIBA 03/2001
1	Proteins (Proteins, Gene)FDA Link 01/2001
1	Estrogen ReceptorsIBA 01/2001
1	Carcinoembryonic AntigenIBA 01/2001
1	PlatinumIBA 12/2000
1	Docetaxel (Taxotere)FDA Link 12/2000
1	CalciumIBA 09/2000
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2000
1	Diphosphonates (Bisphosphonates)IBA 09/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2000
1	Cisplatin (Platino)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Nerve Block (Nerve Blocks) 05/2016
1	Injections 05/2016
1	Sympathectomy (Sympathectomies) 09/2012
1	Renal Dialysis (Hemodialysis) 05/2009
1	Immunotherapy 03/2001
1	Radiotherapy 03/2001
1	Nephrectomy 01/2001
1	Aftercare (After-Treatment) 09/2000
1	Intravenous Infusions 01/2000
1	Therapeutics 01/2000
1	Drug Therapy (Chemotherapy) 01/2000
1	Thoracotomy 01/2000